Reference health
Transcriptomic Signatures and Immunomodulatory Treatments for COVID-19 Patients
67/67 checkable references clean · checked 2026-08-27
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
21 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 67 checked references that resolve
resolves10.3389/fimmu.2020.00827
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
resolves10.1186/s13063-020-04352-9
Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial
resolves10.3410/f.737842320.793575080
Faculty Opinions recommendation of Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
resolves10.1093/nar/gkaa019
Prevalence and architecture of posttranscriptionally impaired synonymous mutations in 8,320 genomes across 22 cancer types
resolves10.1093/nargab/lqaa084
AI-Driver: an ensemble method for identifying driver mutations in personal cancer genomes
resolves10.1093/nar/gkv1308
RBP-Var: a database of functional variants involved in regulation mediated by RNA-binding proteins
resolves10.1093/bioinformatics/btaa224
Potential covalent drugs targeting the main protease of the SARS-CoV-2 coronavirus
resolves10.3390/ijms21093330
Cytokine Release Syndrome in COVID-19 Patients, A New Scenario for an Old Concern: The Fragile Balance between Infections and Autoimmunity
resolves10.1093/nar/gkx918
EpiDenovo: a platform for linking regulatory de novo mutations to developmental epigenetics and diseases
resolves10.1038/s41587-019-0201-4
Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype
resolves10.1093/bioinformatics/bts321
POOL server: machine learning application for functional site prediction in proteins
resolves10.1186/s13059-014-0550-8
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
resolves10.1093/nar/gkaa1033
OncoVar: an integrated database and analysis platform for oncogenic driver variants in cancers
resolves10.1074/jbc.M208602200
Crystal Structure of Interleukin-19 Defines a New Subfamily of Helical Cytokines
resolves10.3389/fimmu.2018.02235
CD22: A Regulator of Innate and Adaptive B Cell Responses and Autoimmunity
resolves10.1016/j.bbi.2016.02.001
Inhibiting neuroinflammation: The role and therapeutic potential of GABA in neuro-immune interactions
resolves10.3389/fncel.2015.00284
Modulation of TLR3/TLR4 inflammatory signaling by the GABAB receptor agonist baclofen in glia and immune cells: relevance to therapeutic effects in multiple sclerosis
resolves10.1136/annrheumdis-2020-217955
Response to: ‘Severe COVID-19 associated pneumonia in 3 patients with systemic sclerosis treated with rituximab' by Avouac et al
resolves10.1111/ajt.15992
Coronavirus disease 2019 and transplantation: The combination of lopinavir/ritonavir and hydroxychloroquine is responsible for excessive tacrolimus trough level and unfavorable outcome
resolves10.1056/nejmoa2001282
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
resolves10.7326/m20-1334
Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know
resolves10.1093/cvr/cvaa106
COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options
resolves10.1101/2020.04.16.20065920
Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19
resolves10.1016/j.cytogfr.2020.06.001
SARS-CoV-2 infection: The role of cytokines in COVID-19 disease
resolves10.1016/j.cytogfr.2020.06.014
A cytokine super cyclone in COVID-19 patients with risk factors: the therapeutic potential of BCG immunization
resolves10.1038/s41423-020-0402-2
Functional exhaustion of antiviral lymphocytes in COVID-19 patients
resolves10.1038/s41422-020-0318-5
Pathological evidence for residual SARS-CoV-2 in pulmonary tissues of a ready-for-discharge patient
resolves10.1038/s41577-020-0312-7
COVID-19: risk for cytokine targeting in chronic inflammatory diseases?
resolves10.1056/nejmoa2015432
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
resolves10.1016/j.bbi.2020.03.031
Nervous system involvement after infection with COVID-19 and other coronaviruses
resolves10.1001/jamaneurol.2020.1127
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China
resolves10.1101/2020.03.21.20037267
Effect of SARS-CoV-2 infection upon male gonadal function: A single center-based study
resolves10.1101/2020.02.18.20024364
Reduction and Functional Exhaustion of T Cells in Patients with Coronavirus Disease 2019 (COVID-19)
resolves10.1016/j.chom.2016.01.007
Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice
resolves10.1016/s0140-6736(20)30858-8
Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed
resolves10.1136/annrheumdis-2020-217362
Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept
resolves10.1073/pnas.2011616117
Reply to Yang et al.: Tocilizumab treatment in COVID-19 patients needs the assessment of the disease severity and timely intervention
resolves10.1111/bjh.16896
Persisting SARS‐CoV‐2 viraemia after rituximab therapy: two cases with fatal outcome and a review of the literature
resolves10.1371/journal.pone.0074082
Host Targeted Activity of Pyrazinamide in Mycobacterium tuberculosis Infection
resolves10.1128/mbio.01120-15
Statins May Decrease the Fatality Rate of Middle East Respiratory Syndrome Infection
resolves10.1016/j.phrs.2020.104803
Statins in coronavirus outbreak: It’s time for experimental and clinical studies
resolves10.5114/aoms.2020.94655
Statins and the COVID-19 main protease: in silico evidence on direct interaction
resolves10.1136/annrheumdis-2020-217460
Role of immunosuppressive therapy in rheumatic diseases concurrent with COVID-19
resolves10.1101/2020.05.04.20074609
Early Short Course Corticosteroids in Hospitalized Patients with COVID-19
resolves10.37473/fic/10.1101/2020.05.04.20074609
Early Short Course Corticosteroids in Hospitalized Patients with COVID-19
resolves10.1016/s2213-8587(20)30149-2
Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection
resolves10.1016/j.jchromb.2008.04.016
Separation of chlorogenic acid from honeysuckle crude extracts by macroporous resins
resolves10.1016/j.ijantimicag.2020.105971
Coronavirus disease 2019 (COVID-19): first indication of efficacy of Gene-Eden-VIR/Novirin in SARS-CoV-2 infection
resolves10.1371/journal.pone.0057285
Curcumin Modulates the Inflammatory Response and Inhibits Subsequent Fibrosis in a Mouse Model of Viral-induced Acute Respiratory Distress Syndrome
resolves10.2217/fvl-2020-0079
Virtual Screening of Immunomodulatory Medicinal Compounds As Promising anti-SARS-CoV-2 Inhibitors
resolves10.1016/j.immuni.2016.04.013
Store-Operated Ca 2+ Entry in Follicular T Cells Controls Humoral Immune Responses and Autoimmunity
resolves10.3390/nu12041181
Optimal Nutritional Status for a Well-Functioning Immune System Is an Important Factor to Protect against Viral Infections
The 21 references without a DOI — listed, not checked
no DOI — not checkedref1
no DOI — not checkedref3
no DOI — not checkedA SARS-CoV-2 protein interaction map reveals 7 targets for drug repurposing
no DOI — not checkedref6
no DOI — not checkedref13
no DOI — not checkedA New Scenario for an Old Concern: The Fragile 29 Balance between Infections and Autoimmunity
no DOI — not checkedref22
no DOI — not checkedRituximab for granulomatosis with polyangiitis in the 25 pandemic of covid-19: lessons from a case with severe pneumonia
no DOI — not checkedref33
no DOI — not checked2020) COVID-19 and the cardiovascular system: 41 implications for risk assessment, diagnosis, and treatment options
no DOI — not checked2020) Pathological evidence for residual SARS-CoV-2 in pulmonary tissues of a 12 ready-for-discharge patient
no DOI — not checkedPulmonary Vascular Endothelialitis, Thrombosis, 17 and Angiogenesis in Covid-19
no DOI — not checkedref51
no DOI — not checkedref54
no DOI — not checkedCause Lethal Pneumonia in SARS-CoV-Infected Mice
no DOI — not checkedPersisting SARS-CoV-2 viremia after rituximab therapy: Two 4 cases with fatal outcome and a review of literature
no DOI — not checkedref76
no DOI — not checkedref82
no DOI — not checkedCOVID-19) Based on Molecular 36 Docking Method
no DOI — not checkedref85
no DOI — not checkedStore-operated Ca2+ entry in follicular T cells controls 11 humoral immune responses and autoimmunity
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-08-27 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.2139/ssrn.3620818"><img src="https://citestamp.com/citestamped/10.2139/ssrn.3620818/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.2139/ssrn.3620818)